Skip to main
PEPG

PepGen Inc (PEPG) Stock Forecast & Price Target

PepGen Inc (PEPG) Analyst Ratings

Based on 5 analyst ratings
Strong Buy
Strong Buy 60%
Buy 40%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

PepGen is a clinical-stage biotechnology company that holds significant potential in the world of oligonucleotide therapeutics. With its Enhanced Delivery Oligonucleotide platform and pipeline products like PGN-EDO51 and PGN-EDODM1, PepGen has created a robust infrastructure to target various neuromuscular and neurologic diseases. With completion of recruitment in the 10mg/kg multi-dose cohort in the FREEDOM2 study, PepGen is poised to have a successful second half of 2026 and could potentially meet or exceed market expectations. The company has also shown promising data in terms of drug concentrations and splicing correction, but it will be important to monitor functional assessments and safety updates in the future. Overall, PepGen's promising pipeline and potential to meet unmet medical needs make it a strong investment opportunity for the future.

Bears say

PepGen is a clinical-stage biotechnology company with a promising Enhanced Delivery Oligonucleotide platform, but concerns remain around their PGN-EDODM1 drug and its splicing data, as seen in previous presentations. The company has experienced delays in potential commercial launches and needs to access external funding for their development platform. Safety concerns also need to be thoroughly addressed, as higher dosing data from their FREEDOM-2 cohort in the second half of 2026 will shed important insights into the PGN-EDODM1 safety and efficacy profile. With the company's current financial status and safety concerns, we have a negative outlook on PepGen's stock.

PepGen Inc (PEPG) has been analyzed by 5 analysts, with a consensus rating of Strong Buy. 60% of analysts recommend a Strong Buy, 40% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of PepGen Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About PepGen Inc (PEPG) Forecast

Analysts have given PepGen Inc (PEPG) a Strong Buy based on their latest research and market trends.

According to 5 analysts, PepGen Inc (PEPG) has a Strong Buy consensus rating as of Jun 3, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $11.60, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $11.60, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

PepGen Inc (PEPG)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.